When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Dec 21 (Reuters) - Federal Reserve Bank of Cleveland President Beth Hammack said she saw no need to change U.S. interest rates for months ahead after the central bank cut borrowing costs at its last ...
The NHS has issued a warning to anyone who has urinary tract infection (UTI) symptoms and also takes warfarin. Urging people to keep an eye out for key symptoms of a UTI, the service says that if ...
ELLISVILLE, Mo. – Officials are renewing a call for justice in a long-unsolved cold-case murder at a St. Louis County Dairy Queen. The Ellisville Police Department is leading the investigation into ...
Digital arrest is not a legal process, but a cyber fraud. In this scam, criminals claim that you are involved in a serious crime through your Aadhaar card, bank account, or a courier service. In the ...
Recursion Pharmaceuticals (RXRX) is upgraded to Buy, driven by promising REC-4881 data and analyst optimism for FAP market potential. REC-4881's Phase 1b/2 results show a 43% median polyp burden ...